Trial · NCT01298570
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression Free Survival (PFS) | Arm A | 6.1 | 95% Confidence Interval 5.5 to 7.3 | Months | |
| Progression Free Survival (PFS) | Arm B | 5.3 | 95% Confidence Interval 4.1 to 6.0 | Months | |
| Overall Response(OR)Rate | Arm A | Complete Response (CR) | 0 | Participants | |
| Overall Response(OR)Rate | Arm B | Complete Response (CR) | 0 | Participants | |
| Overall Response(OR)Rate | Arm A | Partial Response (PR) | 35 | Participants | |
| Overall Response(OR)Rate | Arm B | Partial Response (PR) | 12 | Participants | |
| Overall Response(OR)Rate | Arm A | Other | 67 | Participants | |
| Overall Response(OR)Rate | Arm B | Other | 46 | Participants | |
| Disease Control (DC) Rate | Arm A | Disease Control Total (CR+PR+SD) | 84 | Participants | |
| Disease Control (DC) Rate | Arm B | Disease Control Total (CR+PR+SD) | 43 | Participants | |
| Disease Control (DC) Rate | Arm A | Progression | 18 | Participants | |
| Disease Control (DC) Rate | Arm B | Progression | 15 | Participants | |
| Overall Survival (OS) | Arm A | 13.8 | Full Range 10.5 to 14.8 | Months | |
| Overall Survival (OS) | Arm B | 11.7 | Full Range 9.0 to 15.9 | Months | |
| Drug Metabolism | Arm A | Cycle 1 | 0.68 | Inter-Quartile Range 0.49 to 0.89 | AUC/dose=(ng/mL*h)/(mg/m^2) |
| Drug Metabolism | Arm B | Cycle 1 | 0.63 | Inter-Quartile Range 0.47 to 0.91 | AUC/dose=(ng/mL*h)/(mg/m^2) |
| Drug Metabolism | Arm A | Cycle 2 | 0.59 | Inter-Quartile Range 0.24 to 0.85 | AUC/dose=(ng/mL*h)/(mg/m^2) |
| Drug Metabolism | Arm B | Cycle 2 | 0.72 | Inter-Quartile Range 0.47 to 0.91 | AUC/dose=(ng/mL*h)/(mg/m^2) |
| Percentage of Patients With Severe Adverse Events | Arm A | neutropenia | 41 | percentage of participants | |
| Percentage of Patients With Severe Adverse Events | Arm B | neutropenia | 30 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01298570/results